抗糖尿病药物领域最具影响力的 100 篇论文的文献计量分析

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Future Science OA Pub Date : 2024-01-31 DOI:10.2144/fsoa-2023-0230

Fatima Azam, Muhammad Hamza Dawood, Aroosa Roshan, Maryam Urooj, Zoha Khan, M. O. Larik, Fatima Mustafa Lakdawala, Ahad Yousuf Moulvi, Ifrah Salim, Mehak Abbas Zaidi, Alizeh Imran

{"title":"抗糖尿病药物领域最具影响力的 100 篇论文的文献计量分析","authors":"Fatima Azam, Muhammad Hamza Dawood, Aroosa Roshan, Maryam Urooj, Zoha Khan, M. O. Larik, Fatima Mustafa Lakdawala, Ahad Yousuf Moulvi, Ifrah Salim, Mehak Abbas Zaidi, Alizeh Imran","doi":"10.2144/fsoa-2023-0230","DOIUrl":null,"url":null,"abstract":"Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the ‘top 100 most-cited’. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs\",\"authors\":\"Fatima Azam, Muhammad Hamza Dawood, Aroosa Roshan, Maryam Urooj, Zoha Khan, M. O. Larik, Fatima Mustafa Lakdawala, Ahad Yousuf Moulvi, Ifrah Salim, Mehak Abbas Zaidi, Alizeh Imran\",\"doi\":\"10.2144/fsoa-2023-0230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the ‘top 100 most-cited’. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.\",\"PeriodicalId\":12568,\"journal\":{\"name\":\"Future Science OA\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Science OA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2144/fsoa-2023-0230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2023-0230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

摘要

目的：我们分析了所有抗糖尿病药物中被引用次数最多的 100 篇文章。在全面的文献综述中没有发现这方面的文献计量学研究。方法两名研究人员独立从 Scopus 中提取文章，并按引用次数将其列为 "被引用次数最多的 100 篇文章"。结果引用次数中位数为 1385.5 次。大多数文章来自美国（n = 59）。胰岛素论文最多（24 篇）。大多数论文（n = 76）由私人资助，至少有一篇存在利益冲突（n = 66）。新英格兰医学杂志》发表的论文最多（44 篇）。男性作者在第一作者和最后作者中均占多数。结论本研究旨在帮助指导未来研究，减少偏见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs

Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the ‘top 100 most-cited’. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

5.00

自引率

4.00%

发文量

审稿时长

13 weeks

期刊介绍： Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries